JYOTI BEHL: Open Payments
NPI 1255386157 · GREENBELT, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,654 in 62 payments from 9 companies in 2025. Trend: 2023 $1,451 · 2024 $1,470 · 2025 $1,654
Food & beverage: $1,642Education: $12
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 25 | $739 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 15 | $377 |
| Lundbeck LLC | 10 | $249 |
| Alkermes, Inc. | 3 | $70 |
| Otsuka America Pharmaceutical, Inc. | 3 | $68 |
| Luye Pharma (USA) Ltd. | 2 | $51 |
| ABBVIE INC. | 2 | $43 |
| Janssen Pharmaceuticals, Inc | 1 | $33 |
| E.R. Squibb & Sons, L.L.C. | 1 | $24 |
Products named: FANAPT, CAPLYTA, HETLIOZ, REXULTI, ARISTADA, ERZOFRI EXTENDED-RELEASE, ABILIFY MAINTENA, VRAYLAR.
Industry payments across MD — which companies pay providers there.
